Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rosacea Subtype 1 (Erythematotelangiectatic)”

4 trials

Showing 4 of 4 results

Not applicableStudy completedNCT01666509
What this trial is testing

Efficacy and Tolerability of Topical Rossoseq™ Compared to Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

Who this might be right for
Rosacea Subtype 1 (Erythematotelangiectatic)
PBB Entrepreneur Ltd. 61
Early research (Phase 1)Study completedNCT06776445
What this trial is testing

Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial

Who this might be right for
RosaceaRosacea Subtype 1 (Erythematotelangiectatic)
First Affiliated Hospital of Chongqing Medical University 50
Not applicableNot Yet RecruitingNCT07521462
What this trial is testing

Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy

Who this might be right for
Rosacea, ErythematotelangiectaticRosacea Subtype 1 (Erythematotelangiectatic)
ISISPHARMA 50
Post-approval studies (Phase 4)Study completedNCT07431476
What this trial is testing

Brimonidine 0.33% for Rosacea-Related Facial Erythema

Who this might be right for
RosaceaRosacea Subtype 1 (Erythematotelangiectatic)
Istanbul Training and Research Hospital 45

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation